212 related articles for article (PubMed ID: 11420419)
1. Reduced Na(+), K(+)-ATPase activity in erythrocyte membranes from patients with phenylketonuria.
Bedin M; Estrella CH; Ponzi D; Duarte DV; Dutra-Filho CS; Wyse AT; Wajner M; Wannmacher CM
Pediatr Res; 2001 Jul; 50(1):56-60. PubMed ID: 11420419
[TBL] [Abstract][Full Text] [Related]
2. In vivo effects of high phenylalanine blood levels on Na+,K+-ATPase, Mg2+-ATPase activities and biogenic amine concentrations in phenylketonuria.
Schulpis KH; Tjamouranis J; Karikas GA; Michelakakis H; Tsakiris S
Clin Biochem; 2002 Jun; 35(4):281-5. PubMed ID: 12135689
[TBL] [Abstract][Full Text] [Related]
3. Platelet Na+, K+-ATPase activity as a possible peripheral marker for the neurotoxic effects of phenylalanine in phenylketonuria.
Bedin M; Estrella CH; Duarte DV; Ponzi D; Dutra-Filho CS; Wyse AT; Wajner M; Wannmacher CM
Metab Brain Dis; 2000 Jun; 15(2):115-21. PubMed ID: 11092578
[TBL] [Abstract][Full Text] [Related]
4. Serum E-selectin and erythrocyte membrane Na+K+ ATPase levels in patients with rheumatoid arthritis.
Yildirim K; Senel K; Karatay S; Sisecioglu M; Kiziltunc A; Ugur M; Akcay F
Cell Biochem Funct; 2005; 23(4):285-9. PubMed ID: 15515123
[TBL] [Abstract][Full Text] [Related]
5. [Activity of erythrocyte membrane Na,K-ATPase in rats with experimental botulism].
Chesnokova NP; Kuliash GIu
Biull Eksp Biol Med; 1982 Sep; 94(9):29-31. PubMed ID: 6293618
[TBL] [Abstract][Full Text] [Related]
6. Relation of erythrocyte Na+-K+ ATPase activity and cholesterol and oxidative stress in patients with type 2 diabetes mellitus.
Konukoglu D; Kemerli GD; Sabuncu T; Hatemi H
Clin Invest Med; 2003 Dec; 26(6):279-84. PubMed ID: 14690302
[TBL] [Abstract][Full Text] [Related]
7. [A study of Na(+)-K(+)-ATP ase activity in erythrocyte membrane from diabetic retinopathy patients].
He J; Qiu Y; Zhou X
Zhonghua Yan Ke Za Zhi; 1998 Nov; 34(6):421-3. PubMed ID: 11877243
[TBL] [Abstract][Full Text] [Related]
8. Effects of oxidative stress on the erythrocyte Na+,K+ ATPase activity in female hyperthyroid patients.
Konukoglu D; Yelke HK; Hatemi H; Sabuncu T
J Toxicol Environ Health A; 2001 Jun; 63(4):289-95. PubMed ID: 11437061
[TBL] [Abstract][Full Text] [Related]
9. Effect of aldose reductase inhibitor (Ponalrestat) on erythrocyte Na,K-ATPase activity in non-insulin-dependent diabetic patients with polyneuropathy.
Umeda F; Noda K; Hashimoto T; Yamashita T; Nawata H
Diabetes Res; 1989 Nov; 12(3):125-9. PubMed ID: 2561396
[TBL] [Abstract][Full Text] [Related]
10. Abnormal erythrocyte Na, K-ATPase activity in a northeastern Thai population.
Tosukhowong P; Chotikasatit C; Tungsanga K; Sriboonlue P; Prasongwattana V; Pansin P; Sitprija V
Southeast Asian J Trop Med Public Health; 1992 Sep; 23(3):526-30. PubMed ID: 1336901
[TBL] [Abstract][Full Text] [Related]
11. The effect of diet on total antioxidant status, erythrocyte membrane Na+,K+-ATPase and Mg2+-ATPase activities in patients with classical galactosaemia.
Schulpis KH; Michelakakis H; Tsakiris T; Tsakiris S
Clin Nutr; 2005 Feb; 24(1):151-7. PubMed ID: 15681113
[TBL] [Abstract][Full Text] [Related]
12. The effect of L-cysteine and glutathione on inhibition of Na+, K+-ATPase activity by aspartame metabolites in human erythrocyte membrane.
Schulpis KH; Papassotiriou I; Parthimos T; Tsakiris T; Tsakiris S
Eur J Clin Nutr; 2006 May; 60(5):593-7. PubMed ID: 16391576
[TBL] [Abstract][Full Text] [Related]
13. Na,K-ATPase activity in red blood cells from patients with Chediak-Higashi syndrome.
Proverbio T; Proverbio F; Marín R; Merino F
Exp Mol Pathol; 1995 Jun; 62(3):173-9. PubMed ID: 8612721
[TBL] [Abstract][Full Text] [Related]
14. Hypothesis: low Na/K-ATPase activity in the red cell membrane, a potential marker of the predisposition to diabetic neuropathy.
Raccah D; Gallice P; Pouget J; Vague P
Diabete Metab; 1992; 18(3):236-41. PubMed ID: 1327887
[TBL] [Abstract][Full Text] [Related]
15. Combined effects of lead and EDTA on Na+,K+-ATPase activity of erythrocyte membranes.
Karai I; Lee SI; Horiguchi S; Fukumoto K; Matsumura S; Takise S
J Toxicol Environ Health; 1983; 12(4-6):721-30. PubMed ID: 6321747
[TBL] [Abstract][Full Text] [Related]
16. Studies on the determination of Na-K-ATPase in red blood cell membranes.
Eder K; Reichlmayr-Lais AM; Kirchgessner M
J Trace Elem Electrolytes Health Dis; 1989 Sep; 3(3):151-9. PubMed ID: 2562499
[TBL] [Abstract][Full Text] [Related]
17. Effect of phenylalanine and p-chlorophenylalanine on Na+, K+-ATPase activity in the synaptic plasma membrane from the cerebral cortex of rats.
Streck EL; Edom PT; Noriler ME; Borges LF; Pontes ZL; Parolo E; Dutra-Filho CS; Wannmacher CM; Wyse AT
Metab Brain Dis; 2000 Jun; 15(2):105-14. PubMed ID: 11092577
[TBL] [Abstract][Full Text] [Related]
18. Alteration of erythrocyte membrane Na, K-ATPase in children with borderline or essential hypertension.
Stojadinovic ND; Petronijević MR; Pavićević MH; Mrsulja BB; Kostić MM
Cell Biochem Funct; 1996 Jun; 14(2):79-87. PubMed ID: 8640956
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of membrane Na(+)-K+ Atpase of the brain, liver and RBC in rats administered di(2-ethyl hexyl) phthalate (DEHP) a plasticizer used in polyvinyl chloride (PVC) blood storage bags.
Dhanya CR; Indu AR; Deepadevi KV; Kurup PA
Indian J Exp Biol; 2003 Aug; 41(8):814-20. PubMed ID: 15248477
[TBL] [Abstract][Full Text] [Related]
20. Effect of experimental diabetes on Na/K-ATPase activity in red blood cells, peripheral nerve and kidney.
Raccah D; Lamotte-Jannot MF; Issautier T; Vague P
Diabete Metab; 1994; 20(3):271-4. PubMed ID: 8001715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
